Project Grant R41NS137850
Award Date
6/15/25
Completion Date
5/31/27
Dollars Obligated
$524K
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Wisconsin, USA
Similar Awards
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, is funding a multi-site clinical trial to evaluate the diagnostic and prognostic utility of a Transcranial Magnetic Stimulation-Electroencephalography (TMS-EEG) device for critically ill patients with acute disorders of consciousness. The $2,621,650 award to The General Hospital...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $220,244 to support research conducted by The Trustees of the University of Pennsylvania (UPenn) from January 15, 2025 to December 31, 2029. The research aims to clarify the physiological relevance of brain network connectivity in disorders of consciousness (DOC) after...
This $498,995 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports the development of a highly parallelized interferometric near-infrared spectroscopy (INIRS) platform for the real-time, non-invasive measurement of cerebral blood flow. The research aims to address the limitations of current stroke diagnosis and monitoring techniques...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, is funding the development of an innovative portable device to rapidly detect and monitor traumatic brain injury (TBI) biomarkers. The $332,122 award to Hemex Health Inc. aims to create a point-of-care diagnostic platform that can quickly analyze whole blood samples to identify elevated...
The federal Project Grant award R21NS137987, in the amount of $427,625.00, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The award supports research at the University of Iowa to investigate whether the Transcranial Magnetic Stimulation (TMS)-evoked potential (TEP) in EEG recordings can serve as a non-invasive measure of cortical excitability during...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded Pison Technology, Inc. a $459,097 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The purpose of this Fast-Track Phase I/Phase II project is to assess Pison's neural biosensor technology as a scalable source of a digital biomarker for characterizing disease progression in amyotrophic lateral sclerosis (ALS). The work aims to develop a version...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Cooperative Agreement award of $1,200,991 to Mindtrace Technologies, Inc. will fund the development of a first-of-its-kind "Cognitive Dashboard" tool to support clinical decision-making in neurosurgery. The project aims to create an integrated software platform that combines behavioral testing, functional and structural brain mapping, and predictive analytics to improve pre-operative...
This $830,409 Project Grant award from the National Institute of Mental Health (CFDA 93.242 - Mental Health Research Grants) will fund the development of novel software and computational techniques that integrate real-time electric field mapping, electroencephalogram (EEG) source imaging, and subject-specific targeting to improve the accuracy of transcranial magnetic stimulation (TMS) treatment for brain diseases such as major depressive disorder. The funded work will leverage the SlicerTMS...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) provides $299,982 to support the development of Unandup, LLC's novel magnetic infusion platform technology. The goal is to evaluate the safety and efficacy of this adjunctive thrombolysis system in an in vivo rat model of acute ischemic stroke. The technology aims to accelerate the delivery of...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), funded under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will support a comprehensive $378,453 research study on temporal interference (TI), an innovative non-invasive brain stimulation technique. The 3-year project aims to bridge gaps in understanding how TI functions within the central nervous system, through three specific research...